You are here

patients

Building a strong FDA workforce to bring scientific advances to patients

Building a strong FDA workforce to bring scientific advances to patients

Mass Device

Flag link:

Diabetes drugmakers partner with mobile startups to boost patient engagement

Diabetes drugmakers partner with mobile startups to boost patient engagement

Medical Marketing and Media

Flag link:

Precise Medicines: Matching Patients with the Most Effective Drugs

Precise Medicines: Matching Patients with the Most Effective Drugs

Elsevier

precision medicine

Flag link:

After Bristol-Myers Squibb's Supreme Court win, Johnson & Johnson seeks relief from $300M in talc verdicts

After Bristol-Myers Squibb's Supreme Court win, Johnson & Johnson seeks relief from $300M in talc verdicts

Fierce Pharma

Bristol-Myers Squibb

Flag link:

Judge allows lawsuit on life-ending drugs for terminally ill

Judge allows lawsuit on life-ending drugs for terminally ill

Stat

terminally ill patients

medically-assisted death

Flag link:

Angry cancer patient sues Celgene over 500% jump in Revlimid cost

Angry cancer patient sues Celgene over 500% jump in Revlimid cost

Fierce Pharma

Flag link:

Consumers don't find pharma all that innovative now, but there's hope for the future: Study

Consumers don't find pharma all that innovative now, but there's hope for the future: Study

Fierce Pharma

Flag link:

Why Medication Adherence Needs To Be A National Priority

Why Medication Adherence Needs To Be A National Priority

Forbes

Flag link:

[video]Bristol-Myers Squibb CEO: Critical that treatments reach patients

[video]Bristol-Myers Squibb CEO: Critical that treatments reach patients

Yahoo/CNBC

Bristol-Myers Squibb

Giovanni Caforio

Flag link:

Novartis, IBM Watson collab to optimize care for patients with advanced breast cancer

Novartis, IBM Watson collab to optimize care for patients with advanced breast cancer

Drug Delivery Business News

advanced breast cancer

Flag link:

A New Cancer Drug Helped Almost Everyone Who Took It. Almost. Here's What It Teaches Us

A New Cancer Drug Helped Almost Everyone Who Took It. Almost. Here's What It Teaches Us

Forbes

clinical trials

Flag link:

Here Come the Patients: The Increasing Role of Patient Preferences in FDA Decision-Making

Here Come the Patients: The Increasing Role of Patient Preferences in FDA Decision-Making

ZS Blog

Flag link:

Drug adherence: What you need to know

Drug adherence: What you need to know

BioPharma Dive

Flag link:

Biogen’s Spinraza Witnessed Robust Patient Demand in 1Q17

Biogen’s Spinraza Witnessed Robust Patient Demand in 1Q17

Market Realist

spinal muscular atrophy

Flag link:

New Condé Nast division aims to lure pharma with patient targeting, branded content

New Condé Nast division aims to lure pharma with patient targeting, branded content

Fierce Pharma

DTC advertising

pharma marketing

Flag link:

Patient centricity? Pharma’s there, expert says. It’s regulators who need to catch up

Patient centricity? Pharma’s there, expert says. It’s regulators who need to catch up

Fierce Pharma

Flag link:

Benlysta maker GSK drafts soccer star Boxx to get lupus patients talking

Benlysta maker GSK drafts soccer star Boxx to get lupus patients talking

Fierce Pharma

Flag link:

How patient-reported outcomes are important in a clinical trial

How patient-reported outcomes are important in a clinical trial

Mass Device

clinical trials

patient-reported outcomes

Flag link:

Shire's DTC move to scrap smiling patients for double 'i's pays off—and it thinks other pharmas should take note

Shire's DTC move to scrap smiling patients for double 'i's pays off—and it thinks other pharmas should take note

Fierce Pharma

dry eye disease

Flag link:

Clinical trial enrollment gets harder as patient populations shrink

Clinical trial enrollment gets harder as patient populations shrink

BioPharma Dive

clinical trials

Flag link: